- Associated Press - Wednesday, April 11, 2012

LITTLE ROCK, Ark. (AP) — An Arkansas judge has fined Johnson & Johnson and a subsidiary more than $1.1 billion after a jury found that the companies downplayed and hid risks associated with an antipsychotic drug.

Judge Tim Fox found nearly 240,000 violations under Arkansas’ Medicaid fraud law over Risperdal. Each violation came with a $5,000 fine, setting the total penalty at more than $1.1 billion.

The state sued Johnson & Johnson and subsidiary Janssen Pharmaceuticals Inc. in 2007 over the drug.

Judge Fox issued an additional $11 million fine in the Wednesday ruling for more than 4,500 violations under the state’s deceptive practices act.

Previous Risperdal verdicts against J&J include a $327 million civil penalty in South Carolina.

Texas reached a $158 million settlement with Janssen in January.